Overview
James Jerkins is a Hematologist practicing medicine in Nashville, Tennessee.
Dr. Jerkins is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Chronic Myelomonocytic Leukemia (CMML), Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Graft.
He is actively involved in clinical research, co-authoring 30 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1301 Medical Center Dr Ste 3903, Nashville, TN 37232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Tennessee Oncology Pharmacy Dispensing
Ian Flinn is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Flinn is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Vanderbilt-Ingram Cancer Center
Brian Rini is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Rini is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Prostatectomy.
Vanderbilt Hematology Clinic
Nishitha Reddy is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Reddy is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. James Jerkins
How do I make an appointment with Dr. James Jerkins?
You can book an appointment with Dr. James Jerkins by calling their office at 615-322-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. James Jerkins a top-rated expert for Chronic Myelomonocytic Leukemia (CMML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. James Jerkins is classified as an Distinguished expert for Chronic Myelomonocytic Leukemia (CMML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. James Jerkins specialize in?
While Dr. James Jerkins is a Hematology, they have specific expertise in Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Transplant, and Graft Versus Host Disease (GvHD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. James Jerkins participate in research or clinical trials?
Yes. Dr. James Jerkins has published 23 articles and abstracts on conditions like Chronic Myelomonocytic Leukemia (CMML). You can view a list of Dr. James Jerkins's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. James Jerkins accept my insurance?
Dr. James Jerkins accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 615-322-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow TransplantDr. Jerkins isDistinguished. Learn about Bone Marrow Transplant.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Jerkins isDistinguished. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Jerkins isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Childhood Acute Myeloid LeukemiaDr. Jerkins isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Graft Versus Host Disease (cGvHD)
- Graft Versus Host Disease (GvHD)Dr. Jerkins isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Jerkins isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Adult T-Cell LeukemiaDr. Jerkins isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Jerkins isExperienced. Learn about Agranulocytosis.
- Angioimmunoblastic T-cell LymphomaDr. Jerkins isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Aplastic AnemiaDr. Jerkins isExperienced. Learn about Aplastic Anemia.
- Blood ClotsDr. Jerkins isExperienced. Learn about Blood Clots.